Thursday, September 8, 2016 | 9:00 AM - 5:00 PM
Speakers: Hans-Joachim Anders (Klinikum der Universität München), Caroline Fox (Merck Research Labs), John Cijiang He (The Mount Sinai Medical Center), Matthias Kretzler (University of Michigan), Kevin V Lemley (University of Southern California), Roger C. Wiggins (University of Michigan), Jochen Reiser (RUSH University), and Katalin Susztak (Perelman School of Medicine)
Accumulating evidence supports a role for renal inflammation and podocytopathy in pathogenesis and progression of chronic kidney disease. This symposium will delve into the mechanisms underlying this pathology.
Tuesday, June 28, 2016 | 8:00 AM - 5:30 PM
Keynote Speaker: Giancarlo Comi (Università Vita-Salute San Raffaele)
Explore novel and emerging treatments for multiple sclerosis, including biomarkers and MRI usage in disease diagnosis, prognosis, and monitoring.
Monday, June 13, 2016 | 10:00 AM - 3:30 PM
Speakers: Ruslan M. Medzhitov (Yale School of Medicine, Howard Hughes Medical Institute), Mauro Perretti (The William Harvey Research Institute, Queen Mary University of London), Charles N. Serhan (Brigham and Women's Hospital & Harvard Medical School), Lars Klareskog (Karolinska Institutet), and Kevin J. Tracey (The Feinstein Institute for Medical Research)
This symposium will honor Dr. Charles N. Serhan, the recipient of the 2016 Ross Prize in Molecular Medicine, for his important discoveries in identifying bioactive mediators and cellular pathways critical in the resolution of inflammatory diseases.
Friday, June 3, 2016 | 8:30 AM - 6:00 PM
Speakers: Agnes C. Agunos (Public Health Agency of Canada), Seamus Fanning (University College Dublin), Delia Grace (International Livestock Research Institute), William J. Hall (Wellcome Trust), Francois Malouin (Sherbrooke University), James L. Marsden (Chipotle Mexican Grill), Alan G. Mathew (Purdue University), H. Morgan Scott (Texas A&M University), Stacy E. Sneeringer (USDA), Jaap A. Wagenaar (Utrecht University), and David R. Wolfgang (Pennsylvania State University)
Antibiotics have been used in human and animal medicine for decades. Reducing the use of antibiotics changes the dynamic between the food supply, food safety, and public health. Food safety practices may emerge a catalyst for change.
Thursday, May 26, 2016 | 9:00 AM - 6:00 PM
Featured Speaker: Peter Godfrey-Faussett (UNAIDS)
This event will address the incidence of non-communicable diseases among people living with HIV, describe morbidity and mortality, and explore interactions among HIV, antiretroviral drugs and behavioral factors influencing development and treatment.
Organizers: John Hambor (Boehringer Ingelheim), Sarkis Mazmanian (California Institute of Technology), Nilufer Seth (Pfizer), Erick Young (Boehringer Ingelheim), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)
This eBriefing discusses gut–brain interactions and the possibility of targeting the microbiome with a focus on CNS health.
Edited by Lothar Kanz
(University of Tübingen, Tübingen, Germany), Willem E. Fibbe
(Leiden University Medical Center, Leiden, the Netherlands), Julia Skokowa
(University Hospital Tübingen, Tübingen, Germany), and John E. Dick
(University of Toronto, Toronto, Ontario, Canada)
Commissioned review articles discuss various properites of blood stem cells
Keynote Speakers: Jo Handelsman (White House Office of Science and Technology Policy), W. Ian Lipkin (Columbia University), Curtis Huttenhower (Harvard T.H. Chan School of Public Health), and Coby Schal (North Carolina State University)
This eBriefing reviews work to map the urban metagenome to probe the microbial communities in the buildings and subways, soil and sewers in our cities.
Organizers: Mercedes Beyna (Pfizer), John Hambor (Boehringer Ingelheim), Nilufer Seth (Pfizer), Erick Young (Boehringer Ingelheim), and Sonya Dougal (The New York Academy of Sciences)
Keynote Speaker: Stanislav Dusko Ehrlich (French National Institute for Agricultural Research; King's College London)
This eBriefing focuses on the causal relationships between gut microbiota and intestinal health and disease.